Gyre Therapeutics (GYRE) Total Debt (2010 - 2017)

Gyre Therapeutics (GYRE) has reported Total Debt for 5 consecutive years, with $478000.0 the latest figure, recorded in Q3 2014.

• In Q3 2014, Total Debt fell 64.62% year-over-year to $478000.0; the TTM figure through Sep 2014 stood at $478000.0 (down 64.62% YoY), while the FY2013 annual figure was $1.1 million, down 42.83% from the prior year.
• Total Debt eased to $478000.0 in Q3 2014 per GYRE's latest filing, from $699000.0 in the prior quarter.
• Across five years, Total Debt topped out at $4.3 million in Q2 2011 and bottomed at $478000.0 in Q3 2014.
• Historically, Total Debt has averaged $2.1 million across 5 years, with a median of $2.0 million in 2012.
• Annual changes were most pronounced in 2011 — Total Debt rose 5.49% — and 2014, when it tumbled 64.62%.
• Gyre Therapeutics' Total Debt stood at $3.1 million in 2010, then advanced by 5.49% to $3.2 million in 2011, then plunged by 38.43% to $2.0 million in 2012, then plunged by 42.83% to $1.1 million in 2013, then sank by 57.92% to $478000.0 in 2014.
• Business Quant data shows GYRE's Total Debt at $478000.0 in Q3 2014, $699000.0 in Q2 2014, and $918000.0 in Q1 2014.